AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.7000
+0.0085 (1.23%)
At close: Mar 27, 2026, 4:00 PM EDT
0.6951
-0.0049 (-0.70%)
Pre-market: Mar 30, 2026, 7:53 AM EDT

AIM ImmunoTech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3313221544
Market Cap Growth
-61.13%-75.40%-39.34%44.94%-66.24%-41.48%
Enterprise Value
4.81.279.529.72-17.93-3.29
Last Close Price
0.701.1319.9843.9630.9791.91
PE Ratio
--0.13-0.65-0.73-0.77-2.30
PS Ratio
33.5736.6477.09106.96105.72327.07
PB Ratio
--0.33-9.912.110.390.78
P/TBV Ratio
-0.11-0.19-8.472.090.390.77
P/FCF Ratio
--0.29-0.88-1.02-0.92-3.15
P/OCF Ratio
--0.29-0.88-1.02-0.93-3.16
EV/Sales Ratio
54.5814.4856.0248.11-127.16-24.34
EV/EBITDA Ratio
--0.11-0.49-0.310.910.18
EV/EBIT Ratio
--0.11-0.48-0.300.900.17
EV/FCF Ratio
--0.12-0.64-0.461.110.23
Debt / Equity Ratio
-0.11-0.11-0.300.050.020.00
Debt / EBITDA Ratio
-0.43-0.43-0.15-0.02-0.04-0.01
Debt / FCF Ratio
-0.45-0.45-0.20-0.03-0.05-0.01
Net Debt / Equity Ratio
-0.19-0.190.78-1.21-0.87-0.85
Net Debt / EBITDA Ratio
-0.16-0.160.050.391.702.66
Net Debt / FCF Ratio
-0.17-0.170.070.582.063.44
Asset Turnover
0.010.010.010.010.000.00
Quick Ratio
0.490.490.421.6526.3574.16
Current Ratio
0.530.530.441.6826.6974.61
Return on Equity (ROE)
244.34%251.38%-388.69%-118.94%-40.79%-32.37%
Return on Assets (ROA)
-162.11%-162.11%-141.28%-106.62%-40.58%-30.81%
Return on Invested Capital (ROIC)
1139.06%1139.06%883.47%-2129.86%-286.46%-112.29%
Return on Capital Employed (ROCE)
1704.02%1704.02%-403.43%-128.03%-41.44%-31.26%
Earnings Yield
-472.45%-763.59%-154.75%-136.36%-129.03%-43.48%
FCF Yield
-370.88%-339.86%-113.74%-98.44%-108.64%-31.72%
Buyback Yield / Dilution
-188.95%-188.95%-15.18%-1.12%-1.49%-48.67%
Total Shareholder Return
-188.95%-188.95%-15.18%-1.12%-1.49%-48.67%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q